Best Practice for Breast Carcinoma

Phase-Based Progress Estimates
Emory University/Winship Cancer Institute, Atlanta, GA
Breast Carcinoma+1 More
Best Practice - Other
What conditions do you have?

Study Summary

This clinical trial evaluates the patient reminders and self-referrals via online patient portals and text messaging (PReVenT) intervention for improving adherence to breast cancer screening. Though no doctor referral is required for mammography, adherence to screening mammograms remains low. Barriers to screening mammography can include things like forgetfulness, low motivation, high cost, or lack of knowledge. Patient reminders and self-scheduling assistance may overcome some of these barriers by increasing patients' awareness, motivating them to schedule their mammogram, and improving access by removing the need for a healthcare provider to order the exam. The PReVenT intervention uses online and text-message based patient-reminders and self-referral assistance to increase adherence to breast cancer screening.

Eligible Conditions

  • Breast Carcinoma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

5 Primary · 0 Secondary · Reporting Duration: At 6 months

At 6 months
Assistance with Self-Referral Scheduling
Patient Satisfaction-Qualitative
Patient Satisfaction-Quantitative
Month 6
Completion of Screening Mammogram-Adherence Rate
Completion of Screening Mammogram-Regression Modeling

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Arm II (enhanced usual care)
1 of 2
Arm I (PReVenT intervention)
1 of 2
Active Control
Experimental Treatment

140 Total Participants · 2 Treatment Groups

Primary Treatment: Best Practice · No Placebo Group · N/A

Arm I (PReVenT intervention)Experimental Group · 4 Interventions: Best Practice, Interview, Survey Administration, Planned Notification · Intervention Types: Other, Other, Other, Other
Arm II (enhanced usual care)ActiveComparator Group · 4 Interventions: Best Practice, Interview, Survey Administration, Health Education · Intervention Types: Other, Other, Other, Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at 6 months

Trial Background

Patricia Balthazar, Principal Investigator
Principal Investigator
Emory University
Closest Location: Emory University/Winship Cancer Institute · Atlanta, GA
Photo of Atlanta  1Photo of Atlanta  2Photo of Atlanta  3
2011First Recorded Clinical Trial
2 TrialsResearching Breast Carcinoma
59 CompletedClinical Trials

Eligibility Criteria

Age 18+ · Female Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have an active online patient portal account.
The patient must have a mobile phone number listed in the EMR.
You have at least one primary care visit in our healthcare system between 2015 and 2021.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.